Literature DB >> 36064878

Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?

C J Vinther1,2, L H Poulsen1,2, P Nicolaisen1,2, M L Obling1,2, T H Brix1,2, A P Hermann1,2, L Hegedüs1,2, N R Jørgensen2,3, S Hansen2,4,5, S J Bonnema6.   

Abstract

PURPOSE: This study aimed to compare changes in the bone turnover markers (BTMs)-C-terminal telopeptide of type I collagen (CTX-I) and procollagen I N-terminal peptide (PINP)-with changes in the bone microarchitecture, assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT), during treatment of patients with thyroid dysfunction.
METHODS: In women with newly diagnosed hypo- or hyperthyroidism, HR-pQCT variables, obtained from the tibia and the radius, were compared with BTMs. Data were collected at diagnosis and after at least 12 months of euthyroidism.
RESULTS: 73 women completed the study (hypothyroidism, n = 27; hyperthyroidism, n = 46). Among hyperthyroid patients, correlations were found between changes in BTMs and HR-pQCT variables, primarily for cortical variables in the tibia, i.e. cortical thickness (CTX-I, p < 0.001; PINP, p < 0.001), and volumetric bone mass density (vBMD) (CTX-I, p < 0.001; PINP, p < 0.001). Moreover, correlations between BTMs and estimated bone strength were found. In the hypothyroid subgroup, no significant findings existed after adjustment. Following treatment, less decrease in tibial vBMD was seen among patients with increasing CTX-I compared to those with a decreasing CTX-I level (p = 0.009). Opposite findings applied to PINP, as patients with decreasing PINP showed an increase in tibial vBMD, in contrast to a decline in this parameter among patients with increasing PINP (p < 0.001).
CONCLUSION: Changes in CTX-I and PINP correlated with HR-pQCT variables during the treatment of women with thyroid dysfunction. To some extent, these BTMs reflected the restoration of bone microarchitecture. CTX-I seems to be the most sensitive BTM in treatment-naïve thyroid diseases, while PINP is more useful for monitoring during treatment. TRIAL REGISTRATION NUMBER: NCT02005250. Date: December 9, 2013.
© 2022. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Bone microarchitecture; C-terminal telopeptide of type I collagen; High-resolution peripheral quantitative computed tomography; Hyperthyroidism; Hypothyroidism; Procollagen I N-terminal peptide

Year:  2022        PMID: 36064878     DOI: 10.1007/s40618-022-01907-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  36 in total

1.  Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Calcif Tissue Int       Date:  2005-09-08       Impact factor: 4.333

2.  The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis.

Authors:  Bo Abrahamsen; Henrik L Jørgensen; Anne Sofie Laulund; Mads Nybo; Doug C Bauer; Thomas H Brix; Laszlo Hegedüs
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

Review 3.  Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  Thyroid       Date:  2003-06       Impact factor: 6.568

4.  Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  Thyroid       Date:  2002-05       Impact factor: 6.568

5.  Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort.

Authors:  Bo Abrahamsen; Henrik L Jørgensen; Anne Sofie Laulund; Mads Nybo; Thomas H Brix; Laszlo Hegedüs
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741

Review 6.  The bone remodelling cycle.

Authors:  J S Kenkre; Jhd Bassett
Journal:  Ann Clin Biochem       Date:  2018-03-04       Impact factor: 2.057

Review 7.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

8.  Subclinical thyroid dysfunction and fracture risk: a meta-analysis.

Authors:  Manuel R Blum; Douglas C Bauer; Tinh-Hai Collet; Howard A Fink; Anne R Cappola; Bruno R da Costa; Christina D Wirth; Robin P Peeters; Bjørn O Åsvold; Wendy P J den Elzen; Robert N Luben; Misa Imaizumi; Alexandra P Bremner; Apostolos Gogakos; Richard Eastell; Patricia M Kearney; Elsa S Strotmeyer; Erin R Wallace; Mari Hoff; Graziano Ceresini; Fernando Rivadeneira; André G Uitterlinden; David J Stott; Rudi G J Westendorp; Kay-Tee Khaw; Arnuf Langhammer; Luigi Ferrucci; Jacobijn Gussekloo; Graham R Williams; John P Walsh; Peter Jüni; Drahomir Aujesky; Nicolas Rodondi
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272

9.  Metabolic and clinical consequences of hyperthyroidism on bone density.

Authors:  Jagoda Gorka; Regina M Taylor-Gjevre; Terra Arnason
Journal:  Int J Endocrinol       Date:  2013-07-22       Impact factor: 3.257

Review 10.  Thyroid diseases and bone health.

Authors:  G R Williams; J H D Bassett
Journal:  J Endocrinol Invest       Date:  2017-08-29       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.